Sweden Oncology Clinical Trials Market Size & Outlook

The oncology clinical trials market in Sweden is expected to reach a projected revenue of US$ 646.1 million by 2033. A compound annual growth rate of 5.7% is expected of Sweden oncology clinical trials market from 2026 to 2033.
Revenue, 2025 (US$M)
$422.9
Forecast, 2033 (US$M)
$646.1
CAGR, 2026 - 2033
5.7%
Report Coverage
Sweden

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Sweden oncology clinical trials market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Sweden oncology clinical trials market highlights

  • The Sweden oncology clinical trials market generated a revenue of USD 422.9 million in 2025 and is expected to reach USD 646.1 million by 2033.
  • The Sweden market is expected to grow at a CAGR of 5.7% from 2026 to 2033.
  • In terms of segment, phase iii was the largest revenue generating phase type in 2025.
  • Phase I is the most lucrative phase type segment registering the fastest growth during the forecast period.


Oncology clinical trials market data book summary

Market revenue in 2025USD 422.9 million
Market revenue in 2033USD 646.1 million
Growth rate5.7% (CAGR from 2026 to 2033)
Largest segmentPhase iii
Fastest growing segmentPhase I
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationPhase I, Phase II, Phase III, Phase IV


Other key industry trends

  • In terms of revenue, Sweden accounted for 1.3% of the global oncology clinical trials market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany oncology clinical trials market is projected to lead the regional market in terms of revenue in 2033.
  • Italy is the fastest growing regional market in Europe and is projected to reach USD 2,307.6 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Oncology Clinical Trials Market Companies

Name Profile # Employees HQ Website
PRA Health Sciences View profile 10001+ Raleigh, North Carolina, United States, North America http://prahs.com
Novotech View profile 1001-5000 Sydney, New South Wales, Australia, Oceania http://www.novotech-cro.com/
Syneos Health View profile 1001-5000 Morrisville, North Carolina, United States, North America https://www.syneoshealth.com/
PAREXEL View profile 10001+ Waltham, Massachusetts, United States, North America http://www.parexel.com
IQVIA Holdings Inc View profile 87000 2400 Ellis Road, Durham, NC, United States, 27703 https://www.iqvia.com
Gilead Sciences Inc View profile 18000 333 Lakeside Drive, Foster, CA, United States, 94404 https://www.gilead.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Medpace Holdings Inc View profile 5800 5375 Medpace Way, Cincinnati, OH, United States, 45227 https://www.medpace.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Roche Holding AG ADR View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com

Sweden oncology clinical trials market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oncology clinical trials market will help companies and investors design strategic landscapes.


Phase iii was the largest segment with a revenue share of 65.78% in 2025. Horizon Databook has segmented the Sweden oncology clinical trials market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Sweden oncology clinical trials market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Sweden oncology clinical trials market databook

  • Our clientele includes a mix of oncology clinical trials market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Sweden oncology clinical trials market , including forecasts for subscribers. This country databook contains high-level insights into Sweden oncology clinical trials market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Sweden oncology clinical trials market size, by phase type, 2021-2033 (US$M)

Sweden Oncology Clinical Trials Market Outlook Share, 2025 & 2033 (US$M)

Sweden oncology clinical trials market size, by phase type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online